Risdiplam FDA approval date

The FDA approved Risdiplam (Evrysdi) on 7 Aug 2020.

FDA approval date
7 Aug 2020

Drug identity checked against registry records

Also recorded as Evrysdi

Included trials

PDUFA dates and FDA decisions

Date as reportedDrug / companyEventConditionEvidence
2020-08-07DayRisdiplamFDA original application approvalFDA approval decisionNot specifiedOpen original source
Read source excerpt

{"application_number": "NDA213535", "applicant_as_listed_by_fda": "GENENTECH INC", "brand_names": ["EVRYSDI"], "active_ingredients": ["RISDIPLAM"], "submission_type": "ORIG", "submission_number": "1", "submission_status": "AP", "submission_status_date": "20200807", "matched_on": "drug name equals FDA sole active ingredient"}

First seen: 06 Oct 2026 · Evidence last checked: 06 Oct 2026